Literature DB >> 21240343

Study of anti-ischemic effect of afobazole in experimental myocardial infarction.

S A Kryzhanovskyi1, A V Sorokina, V N Stolyaruck, M B Vititnova, I A Miroshkina, I B Tsorin, A D Durnev, S B Seredenin.   

Abstract

Seven-day treatment of rats with experimental myocardial infarction with afobazole (5-ethoxy-2-[2-morpholino)-ethylthio] benzimidasole dihydrochloride) resulted in shrinkage of the ischemic damage area in the heart, stimulation of reparative processes in the myocardium, and prevention of postinfarction remodeling of the left ventricle. Anti-ischemic effect of afobazole in experimental myocardial infarction is presumably due to its interactions with σ(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21240343     DOI: 10.1007/s10517-011-1131-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Contribution of Sigma-1 receptor to cytoprotective effect of afobazole.

Authors:  Mikhail V Voronin; Ilya A Kadnikov
Journal:  Pharmacol Res Perspect       Date:  2016-11-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.